Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.
Gilmore R, Fernandes R, Hartley I, Arzivian A, Leong R, Andrew B, Vasudevan A, Greeve T, Moore GT, Kim S, Lightowler D, Singh A, Mahy G, Mithanthaya A, Venugopaul K, Han S, Bryant R, West J, Segal J, Christensen B, Corte C, Ding N, An YK, Begun J.
Gilmore R, et al. Among authors: west j.
Intest Res. 2024 Dec 20. doi: 10.5217/ir.2024.00127. Online ahead of print.
Intest Res. 2024.
PMID: 39709985
Free article.